Charles Ryhee
Stock Analyst at TD Cowen
(1.54)
# 3,202
Out of 4,670 analysts
24
Total ratings
38.1%
Success rate
-4.92%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $8.66 | +61.66% | 6 | Oct 22, 2024 | |
| CVS CVS Health | Upgrades: Buy | $59 → $85 | $58.01 | +46.53% | 4 | Oct 4, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $623.19 | +4.62% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $162.36 | +4.71% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $11.25 | +424.44% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $121.84 | -40.91% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.82 | +44,405.49% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $10.62 | +1,670.24% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $15.98 | +81.48% | 1 | Mar 29, 2021 |
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $8.66
Upside: +61.66%
CVS Health
Oct 4, 2024
Upgrades: Buy
Price Target: $59 → $85
Current: $58.01
Upside: +46.53%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $623.19
Upside: +4.62%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $162.36
Upside: +4.71%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $11.25
Upside: +424.44%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $121.84
Upside: -40.91%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.82
Upside: +44,405.49%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $10.62
Upside: +1,670.24%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $15.98
Upside: +81.48%